MLND - Millendo Therapeutic...

Valuation of Millendo Therapeutics, Inc.(MLND), Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel tre

Millendo Therapeutics, Inc.

MLND

NASDAQ

Inactive Equity

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

1.06 USD

-0.06000006 (-5.66%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Jun 28, 2021 12:00 AM

Share Price on Valuation Date

$1.06

Stock Beta

0.476276

Shares Outstanding

10517100

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.